Global Normothermic Organ Perfusion Systems for Transplantation Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Normothermic Organ Perfusion Systems for Transplantation market size was valued at US$ 526 million in 2025 and is forecast to a readjusted size of US$ 1489 million by 2032 with a CAGR of 15.1% during review period.
Normothermic Organ Perfusion Systems for Transplantation are medical device platforms designed to preserve, assess and support donor organs outside the body under near-physiological temperature conditions, generally around 35–37°C. Unlike static cold storage, these systems maintain active circulation and oxygenation and can provide nutrients, temperature control and real-time physiological monitoring, enabling donor organs to remain metabolically active during preservation and evaluation. Commercial systems typically consist of a reusable perfusion console, pumping and oxygenation modules, temperature-control and monitoring units, organ-specific chambers and single-use perfusion circuits, with dedicated perfusates and other consumables forming an important recurring-revenue component. Current commercial applications are concentrated in liver, heart, lung and kidney transplantation, with deployment models ranging from center-based perfusion to transport-enabled platforms that can maintain active perfusion between donor recovery and recipient implantation. The market is primarily driven by the need to extend preservation windows, improve organ viability assessment, increase utilization of donation after circulatory death and marginal donor organs, and reduce the constraints associated with ischemic injury.
A second trend is the integration of perfusion technology with procurement and transportation infrastructure. Portable systems reduce the dependence of transplant activity on conventional cold ischemic time and make longer-distance organ recovery more practical. In Europe, investments announced in 2025–2026 indicate that integrated transplantation networks combining perfusion, clinical teams and dedicated ground and air logistics are moving beyond the U.S. model. Product development is also expanding toward kidney perfusion, greater automation and remote monitoring, which could broaden NMP from relatively concentrated liver, heart and lung use toward much larger transplant populations over the longer term.
The midstream consists of specialized organ perfusion system manufacturers responsible for system integration, regulatory approval, clinical validation, disposable manufacturing and technical support. Downstream users include transplant centers and hospitals, organ procurement and recovery organizations and, to a smaller extent, academic and research institutions. The increasing integration of organ recovery, perfusion management and logistics is making the boundary between medical-device manufacturing and transplant services more complex, although product revenue remains principally driven by installed platforms and procedure-linked consumables.
The highest-value platforms combine hardware, organ-specific consumables, software, clinical workflow support and logistics compatibility. Consequently, competitive advantage tends to strengthen as installed base and procedure volumes expand: more procedures create clinical data, support physician familiarity and increase recurring consumable demand. This creates relatively high switching barriers once a transplant center has established protocols, training and reimbursement processes around a particular platform.
By application, Organ Preservation & Transplant Preparation remains the largest category. Organ Viability Assessment is increasingly embedded into NMP workflows, particularly for organs with uncertain quality. Marginal Donor Organ Recovery is a smaller but strategically important growth segment because the commercial value of NMP increasingly depends on converting previously declined organs into transplantable grafts. Other applications include research, therapeutic conditioning and emerging organ-repair approaches, but these remain less commercialized.
Longer term, the opportunity extends beyond preservation alone. Continuous physiological data generated during NMP may support more standardized organ acceptance decisions, treatment of donor organs outside the body and eventually data-driven or algorithm-assisted viability assessment. These capabilities could increase the value of perfusion platforms even without equivalent growth in the number of donor organs.
Europe represents the second major technology and commercialization cluster, with established capabilities in liver, lung and abdominal organ perfusion and a growing emphasis on integrated logistics. Asia Pacific remains comparatively early in commercial adoption but presents meaningful long-term potential because of large populations, expanding transplant capabilities and increasing domestic medical-device development. China has begun developing indigenous NMP equipment, although commercial scale and installed base remain considerably below those of North America and Europe.
Regional competition is structurally differentiated. North America has the deepest commercialization and integrated service infrastructure, Europe has a broader base of specialized organ preservation technologies and strong liver and lung perfusion expertise, while China is emerging from clinical translation toward domestic commercialization. Consolidation is also becoming more important: strategic acquisitions are allowing larger medical-device groups to enter organ preservation technology while providing specialized perfusion businesses with manufacturing scale, regulatory resources and international distribution. The result is likely to remain a relatively concentrated global supplier base even as procedure volumes and geographic adoption expand.
Global Normothermic Organ Perfusion Systems for Transplantation market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Normothermic Organ Perfusion Systems for Transplantation market size and forecasts, by Target Organ and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Normothermic Organ Perfusion Systems for Transplantation market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Normothermic Organ Perfusion Systems for Transplantation market is split by Target Organ and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Target Organ, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Chapter 2, to profile the top manufacturers of Normothermic Organ Perfusion Systems for Transplantation, with price, sales quantity, revenue, and global market share of Normothermic Organ Perfusion Systems for Transplantation from 2021 to 2026.
Chapter 3, the Normothermic Organ Perfusion Systems for Transplantation competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Normothermic Organ Perfusion Systems for Transplantation breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Target Organ and by Application, with sales market share and growth rate by Target Organ, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Normothermic Organ Perfusion Systems for Transplantation market forecast, by regions, by Target Organ, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Normothermic Organ Perfusion Systems for Transplantation.
Chapter 14 and 15, to describe Normothermic Organ Perfusion Systems for Transplantation sales channel, distributors, customers, research findings and conclusion.
Normothermic Organ Perfusion Systems for Transplantation are medical device platforms designed to preserve, assess and support donor organs outside the body under near-physiological temperature conditions, generally around 35–37°C. Unlike static cold storage, these systems maintain active circulation and oxygenation and can provide nutrients, temperature control and real-time physiological monitoring, enabling donor organs to remain metabolically active during preservation and evaluation. Commercial systems typically consist of a reusable perfusion console, pumping and oxygenation modules, temperature-control and monitoring units, organ-specific chambers and single-use perfusion circuits, with dedicated perfusates and other consumables forming an important recurring-revenue component. Current commercial applications are concentrated in liver, heart, lung and kidney transplantation, with deployment models ranging from center-based perfusion to transport-enabled platforms that can maintain active perfusion between donor recovery and recipient implantation. The market is primarily driven by the need to extend preservation windows, improve organ viability assessment, increase utilization of donation after circulatory death and marginal donor organs, and reduce the constraints associated with ischemic injury.
Key Findings
- In 2025, the average selling price of commercial normothermic organ perfusion systems worldwide was approximately US$150,000–250,000 per unit.
- The industry’s overall gross margin remained at approximately 55%–70% in 2025.
- Liver normothermic perfusion remained the largest commercial organ segment.
- North America remained the largest value market globally.
- Organ preservation and transplant preparation remained the largest application segment.
Market Trends
The principal technology trend is the transition from passive preservation toward active organ management. Normothermic perfusion maintains donor organs in a functioning or near-functioning physiological state and creates a time window in which clinicians can observe hemodynamic, metabolic and organ-specific parameters before implantation. This is changing the role of preservation technology from simple time extension to a broader combination of preservation, functional assessment and potentially therapeutic intervention. The commercial direction is also shifting toward organ-specific protocols built on common platform architectures, enabling manufacturers to leverage pumps, monitoring, temperature control, software and disposable technologies across multiple transplant indications.A second trend is the integration of perfusion technology with procurement and transportation infrastructure. Portable systems reduce the dependence of transplant activity on conventional cold ischemic time and make longer-distance organ recovery more practical. In Europe, investments announced in 2025–2026 indicate that integrated transplantation networks combining perfusion, clinical teams and dedicated ground and air logistics are moving beyond the U.S. model. Product development is also expanding toward kidney perfusion, greater automation and remote monitoring, which could broaden NMP from relatively concentrated liver, heart and lung use toward much larger transplant populations over the longer term.
Market Dynamics
Drivers
The central market driver is the persistent shortage of transplantable donor organs. U.S. transplant activity reached 46,750 solid-organ procedures in 2024, while 167,230 unique patients were present on transplant waiting lists during the year. At the same time, a meaningful proportion of recovered organs remain unused, including 29.3% of recovered kidneys and 11.3% of recovered lungs in 2024. Technologies that can provide functional assessment and improve confidence in marginal or DCD organs therefore have a direct clinical and economic rationale.Restraints
High equipment and procedure-related costs remain the principal restraint. Commercial NMP requires not only a perfusion console but also organ-specific disposable sets, perfusion solutions, trained personnel and workflow integration. Adoption is consequently concentrated in high-volume transplant centers and healthcare systems capable of supporting specialized operating procedures and reimbursement requirements. Clinical evidence and regulatory approvals are also organ-specific, limiting the ability of manufacturers to transfer commercial success from one organ indication directly to another.Opportunities
The largest structural opportunity lies in increasing utilization of organs that would otherwise be declined. DCD transplantation, extended-criteria donors, longer-distance donor recovery and objective viability assessment all enlarge the addressable procedure pool without requiring a proportional increase in donor availability. Kidney transplantation represents an especially significant longer-term opportunity because kidney transplant volumes are substantially larger than liver, heart or lung volumes, while current commercial NMP penetration remains limited. Next-generation platforms incorporating automation, continuous data collection and remote monitoring could also reduce operating complexity and extend the technology beyond a relatively small group of specialist centers.Challenges
The industry must demonstrate that higher preservation costs translate into improved organ utilization, clinical outcomes or transplant-center productivity. Evidence requirements are substantial because performance must be established separately across organs, donor populations and clinical protocols. Operational reliability is also critical: the equipment supports viable donor organs during time-sensitive transplantation processes, so pump failure, temperature instability, disposable-set problems or logistical interruptions can carry unusually high consequences. Scaling manufacturing and clinical-support capacity while maintaining quality systems is therefore a major barrier for emerging suppliers.Industry Chain Analysis
The upstream industry includes medical-grade pumps, oxygenators, heat exchangers, pressure and flow sensors, temperature-control components, sterile tubing, organ chambers, electronic control systems, embedded software and pharmaceutical-grade perfusion solutions. Because the system operates directly with transplantable organs, suppliers must meet stringent requirements for biocompatibility, sterility, reliability and traceability. Manufacturers typically retain control over core console design, organ-specific disposable circuits, software algorithms and clinical protocols, while sourcing selected pumps, sensors, plastics and electronic components from qualified medical-device supply chains.The midstream consists of specialized organ perfusion system manufacturers responsible for system integration, regulatory approval, clinical validation, disposable manufacturing and technical support. Downstream users include transplant centers and hospitals, organ procurement and recovery organizations and, to a smaller extent, academic and research institutions. The increasing integration of organ recovery, perfusion management and logistics is making the boundary between medical-device manufacturing and transplant services more complex, although product revenue remains principally driven by installed platforms and procedure-linked consumables.
Value Chain Analysis
Value creation is concentrated less in conventional hardware manufacturing than in proprietary organ-specific perfusion protocols, clinical evidence, regulatory approvals, disposable ecosystems and transplant-center integration. Reusable consoles can be sold, leased or placed to accelerate installed-base expansion, while recurring disposable perfusion sets and dedicated solutions provide a more scalable source of revenue. XVIVO explicitly identifies disposable sales rather than machines as the primary profitability driver in both its thoracic and abdominal businesses, illustrating the importance of procedure-linked recurring consumption.The highest-value platforms combine hardware, organ-specific consumables, software, clinical workflow support and logistics compatibility. Consequently, competitive advantage tends to strengthen as installed base and procedure volumes expand: more procedures create clinical data, support physician familiarity and increase recurring consumable demand. This creates relatively high switching barriers once a transplant center has established protocols, training and reimbursement processes around a particular platform.
Segment Insights
By target organ, liver represents the largest commercial segment, followed by heart and lung, while kidney NMP remains a comparatively early commercial opportunity. Liver NMP has established a particularly strong clinical proposition because viability can be assessed through multiple functional and biochemical indicators and because DCD liver transplantation has expanded rapidly. Heart perfusion represents a high-value application where transport time and DCD utilization are central considerations, while lung perfusion benefits from the established concept of ex vivo lung assessment. Kidney transplantation provides the largest procedure base but currently relies heavily on cold storage and hypothermic machine perfusion, leaving substantial room for NMP development.By application, Organ Preservation & Transplant Preparation remains the largest category. Organ Viability Assessment is increasingly embedded into NMP workflows, particularly for organs with uncertain quality. Marginal Donor Organ Recovery is a smaller but strategically important growth segment because the commercial value of NMP increasingly depends on converting previously declined organs into transplantable grafts. Other applications include research, therapeutic conditioning and emerging organ-repair approaches, but these remain less commercialized.
Downstream Market Opportunities
High-volume transplant centers remain the most attractive downstream customers because system utilization directly determines disposable consumption and economic efficiency. Centers seeking to expand transplant volumes, accept organs from greater distances or increase DCD utilization have the strongest incentive to adopt active perfusion technologies. Organ procurement and recovery organizations also represent an increasingly important channel as transplantation shifts toward centralized recovery, specialist perfusion teams and coordinated logistics.Longer term, the opportunity extends beyond preservation alone. Continuous physiological data generated during NMP may support more standardized organ acceptance decisions, treatment of donor organs outside the body and eventually data-driven or algorithm-assisted viability assessment. These capabilities could increase the value of perfusion platforms even without equivalent growth in the number of donor organs.
Regional Insights
North America remains the largest and most commercially developed market. The U.S. combines high transplant procedure volumes, established reimbursement pathways, rapid growth in DCD transplantation and broad adoption of integrated organ perfusion and procurement models. TransMedics disclosed that U.S. liver OCS penetration reached 36% and heart penetration 18% in 2025, illustrating that active perfusion has already moved beyond early clinical adoption in selected indications.Europe represents the second major technology and commercialization cluster, with established capabilities in liver, lung and abdominal organ perfusion and a growing emphasis on integrated logistics. Asia Pacific remains comparatively early in commercial adoption but presents meaningful long-term potential because of large populations, expanding transplant capabilities and increasing domestic medical-device development. China has begun developing indigenous NMP equipment, although commercial scale and installed base remain considerably below those of North America and Europe.
Competitive Landscape Analysis
The market remains highly concentrated because clinical evidence, regulatory approvals, manufacturing quality systems and transplant-center training create substantial entry barriers. Competition is not based solely on hardware specifications. The leading competitive models include portable multi-organ warm-perfusion platforms integrated with procurement and logistics, liver-focused transport-enabled NMP systems, lung-centered ex vivo perfusion platforms and multi-temperature abdominal perfusion systems capable of supporting several machine-perfusion protocols.Regional competition is structurally differentiated. North America has the deepest commercialization and integrated service infrastructure, Europe has a broader base of specialized organ preservation technologies and strong liver and lung perfusion expertise, while China is emerging from clinical translation toward domestic commercialization. Consolidation is also becoming more important: strategic acquisitions are allowing larger medical-device groups to enter organ preservation technology while providing specialized perfusion businesses with manufacturing scale, regulatory resources and international distribution. The result is likely to remain a relatively concentrated global supplier base even as procedure volumes and geographic adoption expand.
Report Scope
This report is a detailed and comprehensive analysis for global Normothermic Organ Perfusion Systems for Transplantation market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Target Organ and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.Key Features:
Global Normothermic Organ Perfusion Systems for Transplantation market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032Global Normothermic Organ Perfusion Systems for Transplantation market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Normothermic Organ Perfusion Systems for Transplantation market size and forecasts, by Target Organ and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Normothermic Organ Perfusion Systems for Transplantation market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Normothermic Organ Perfusion Systems for Transplantation
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Normothermic Organ Perfusion Systems for Transplantation market is split by Target Organ and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Target Organ, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market Segmentation
Market segment by Target Organ
- Liver
- Heart
- Lung
- Kidney
- Others
Market segment by Target Organ
- Blood-based Perfusate
- Acellular Perfusate
- Others
Market segment by Donor Type
- Donation after Brain Death DBD
- Donation after Circulatory Death DCD
- Others
Market segment by Application
- Hospitals Transplant Centers
- Organ Procurement Organizations (OPOs)
- Specialty Clinics
- Research Laboratories
- Others
Major players covered
- Terumo Corporation
- TransMedics Group, Inc.
- XVIVO Perfusion AB
- Aferetica S.r.l.
- Beijing TsingHan Medical Technology Co., Ltd.
- EBERS Medical Technology S.L.
Market segment by region, regional analysis covers
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Normothermic Organ Perfusion Systems for Transplantation product scope, market overview, market estimation caveats and base year.Chapter 2, to profile the top manufacturers of Normothermic Organ Perfusion Systems for Transplantation, with price, sales quantity, revenue, and global market share of Normothermic Organ Perfusion Systems for Transplantation from 2021 to 2026.
Chapter 3, the Normothermic Organ Perfusion Systems for Transplantation competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Normothermic Organ Perfusion Systems for Transplantation breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Target Organ and by Application, with sales market share and growth rate by Target Organ, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Normothermic Organ Perfusion Systems for Transplantation market forecast, by regions, by Target Organ, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Normothermic Organ Perfusion Systems for Transplantation.
Chapter 14 and 15, to describe Normothermic Organ Perfusion Systems for Transplantation sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Target Organ
1.3.1 Overview: Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Target Organ: 2021 Versus 2025 Versus 2032
1.3.2 Liver
1.3.3 Heart
1.3.4 Lung
1.3.5 Kidney
1.3.6 Others
1.4 Market Analysis by Target Organ
1.4.1 Overview: Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Target Organ: 2021 Versus 2025 Versus 2032
1.4.2 Blood-based Perfusate
1.4.3 Acellular Perfusate
1.4.4 Others
1.5 Market Analysis by Donor Type
1.5.1 Overview: Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Donor Type: 2021 Versus 2025 Versus 2032
1.5.2 Donation after Brain Death DBD
1.5.3 Donation after Circulatory Death DCD
1.5.4 Others
1.6 Market Analysis by Application
1.6.1 Overview: Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospitals Transplant Centers
1.6.3 Organ Procurement Organizations (OPOs)
1.6.4 Specialty Clinics
1.6.5 Research Laboratories
1.6.6 Others
1.7 Global Normothermic Organ Perfusion Systems for Transplantation Market Size & Forecast
1.7.1 Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity (2021-2032)
1.7.3 Global Normothermic Organ Perfusion Systems for Transplantation Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Terumo Corporation
2.1.1 Terumo Corporation Details
2.1.2 Terumo Corporation Major Business
2.1.3 Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Product and Services
2.1.4 Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Terumo Corporation Recent Developments/Updates
2.2 TransMedics Group, Inc.
2.2.1 TransMedics Group, Inc. Details
2.2.2 TransMedics Group, Inc. Major Business
2.2.3 TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Product and Services
2.2.4 TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 TransMedics Group, Inc. Recent Developments/Updates
2.3 XVIVO Perfusion AB
2.3.1 XVIVO Perfusion AB Details
2.3.2 XVIVO Perfusion AB Major Business
2.3.3 XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Product and Services
2.3.4 XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 XVIVO Perfusion AB Recent Developments/Updates
2.4 Aferetica S.r.l.
2.4.1 Aferetica S.r.l. Details
2.4.2 Aferetica S.r.l. Major Business
2.4.3 Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Product and Services
2.4.4 Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Aferetica S.r.l. Recent Developments/Updates
2.5 Beijing TsingHan Medical Technology Co., Ltd.
2.5.1 Beijing TsingHan Medical Technology Co., Ltd. Details
2.5.2 Beijing TsingHan Medical Technology Co., Ltd. Major Business
2.5.3 Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Product and Services
2.5.4 Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Beijing TsingHan Medical Technology Co., Ltd. Recent Developments/Updates
2.6 EBERS Medical Technology S.L.
2.6.1 EBERS Medical Technology S.L. Details
2.6.2 EBERS Medical Technology S.L. Major Business
2.6.3 EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Product and Services
2.6.4 EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 EBERS Medical Technology S.L. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NORMOTHERMIC ORGAN PERFUSION SYSTEMS FOR TRANSPLANTATION BY MANUFACTURER
3.1 Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Manufacturer (2021-2026)
3.2 Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Manufacturer (2021-2026)
3.3 Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Normothermic Organ Perfusion Systems for Transplantation by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Normothermic Organ Perfusion Systems for Transplantation Manufacturer Market Share in 2025
3.4.3 Top 6 Normothermic Organ Perfusion Systems for Transplantation Manufacturer Market Share in 2025
3.5 Normothermic Organ Perfusion Systems for Transplantation Market: Overall Company Footprint Analysis
3.5.1 Normothermic Organ Perfusion Systems for Transplantation Market: Region Footprint
3.5.2 Normothermic Organ Perfusion Systems for Transplantation Market: Company Product Type Footprint
3.5.3 Normothermic Organ Perfusion Systems for Transplantation Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Normothermic Organ Perfusion Systems for Transplantation Market Size by Region
4.1.1 Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Region (2021-2032)
4.1.2 Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Region (2021-2032)
4.1.3 Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Region (2021-2032)
4.2 North America Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032)
4.3 Europe Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032)
4.4 Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032)
4.5 South America Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032)
4.6 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032)
5 MARKET SEGMENT BY TARGET ORGAN
5.1 Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2032)
5.2 Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Target Organ (2021-2032)
5.3 Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2032)
6.2 Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Application (2021-2032)
6.3 Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2032)
7.2 North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2032)
7.3 North America Normothermic Organ Perfusion Systems for Transplantation Market Size by Country
7.3.1 North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2021-2032)
7.3.2 North America Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2032)
8.2 Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2032)
8.3 Europe Normothermic Organ Perfusion Systems for Transplantation Market Size by Country
8.3.1 Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2021-2032)
8.3.2 Europe Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2032)
9.2 Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Market Size by Region
9.3.1 Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2032)
10.2 South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2032)
10.3 South America Normothermic Organ Perfusion Systems for Transplantation Market Size by Country
10.3.1 South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2021-2032)
10.3.2 South America Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2032)
11.2 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Market Size by Country
11.3.1 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Normothermic Organ Perfusion Systems for Transplantation Market Drivers
12.2 Normothermic Organ Perfusion Systems for Transplantation Market Restraints
12.3 Normothermic Organ Perfusion Systems for Transplantation Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Normothermic Organ Perfusion Systems for Transplantation and Key Manufacturers
13.2 Manufacturing Costs Percentage of Normothermic Organ Perfusion Systems for Transplantation
13.3 Normothermic Organ Perfusion Systems for Transplantation Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Normothermic Organ Perfusion Systems for Transplantation Typical Distributors
14.3 Normothermic Organ Perfusion Systems for Transplantation Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Target Organ
1.3.1 Overview: Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Target Organ: 2021 Versus 2025 Versus 2032
1.3.2 Liver
1.3.3 Heart
1.3.4 Lung
1.3.5 Kidney
1.3.6 Others
1.4 Market Analysis by Target Organ
1.4.1 Overview: Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Target Organ: 2021 Versus 2025 Versus 2032
1.4.2 Blood-based Perfusate
1.4.3 Acellular Perfusate
1.4.4 Others
1.5 Market Analysis by Donor Type
1.5.1 Overview: Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Donor Type: 2021 Versus 2025 Versus 2032
1.5.2 Donation after Brain Death DBD
1.5.3 Donation after Circulatory Death DCD
1.5.4 Others
1.6 Market Analysis by Application
1.6.1 Overview: Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospitals Transplant Centers
1.6.3 Organ Procurement Organizations (OPOs)
1.6.4 Specialty Clinics
1.6.5 Research Laboratories
1.6.6 Others
1.7 Global Normothermic Organ Perfusion Systems for Transplantation Market Size & Forecast
1.7.1 Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity (2021-2032)
1.7.3 Global Normothermic Organ Perfusion Systems for Transplantation Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Terumo Corporation
2.1.1 Terumo Corporation Details
2.1.2 Terumo Corporation Major Business
2.1.3 Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Product and Services
2.1.4 Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Terumo Corporation Recent Developments/Updates
2.2 TransMedics Group, Inc.
2.2.1 TransMedics Group, Inc. Details
2.2.2 TransMedics Group, Inc. Major Business
2.2.3 TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Product and Services
2.2.4 TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 TransMedics Group, Inc. Recent Developments/Updates
2.3 XVIVO Perfusion AB
2.3.1 XVIVO Perfusion AB Details
2.3.2 XVIVO Perfusion AB Major Business
2.3.3 XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Product and Services
2.3.4 XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 XVIVO Perfusion AB Recent Developments/Updates
2.4 Aferetica S.r.l.
2.4.1 Aferetica S.r.l. Details
2.4.2 Aferetica S.r.l. Major Business
2.4.3 Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Product and Services
2.4.4 Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Aferetica S.r.l. Recent Developments/Updates
2.5 Beijing TsingHan Medical Technology Co., Ltd.
2.5.1 Beijing TsingHan Medical Technology Co., Ltd. Details
2.5.2 Beijing TsingHan Medical Technology Co., Ltd. Major Business
2.5.3 Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Product and Services
2.5.4 Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Beijing TsingHan Medical Technology Co., Ltd. Recent Developments/Updates
2.6 EBERS Medical Technology S.L.
2.6.1 EBERS Medical Technology S.L. Details
2.6.2 EBERS Medical Technology S.L. Major Business
2.6.3 EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Product and Services
2.6.4 EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 EBERS Medical Technology S.L. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NORMOTHERMIC ORGAN PERFUSION SYSTEMS FOR TRANSPLANTATION BY MANUFACTURER
3.1 Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Manufacturer (2021-2026)
3.2 Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Manufacturer (2021-2026)
3.3 Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Normothermic Organ Perfusion Systems for Transplantation by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Normothermic Organ Perfusion Systems for Transplantation Manufacturer Market Share in 2025
3.4.3 Top 6 Normothermic Organ Perfusion Systems for Transplantation Manufacturer Market Share in 2025
3.5 Normothermic Organ Perfusion Systems for Transplantation Market: Overall Company Footprint Analysis
3.5.1 Normothermic Organ Perfusion Systems for Transplantation Market: Region Footprint
3.5.2 Normothermic Organ Perfusion Systems for Transplantation Market: Company Product Type Footprint
3.5.3 Normothermic Organ Perfusion Systems for Transplantation Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Normothermic Organ Perfusion Systems for Transplantation Market Size by Region
4.1.1 Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Region (2021-2032)
4.1.2 Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Region (2021-2032)
4.1.3 Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Region (2021-2032)
4.2 North America Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032)
4.3 Europe Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032)
4.4 Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032)
4.5 South America Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032)
4.6 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032)
5 MARKET SEGMENT BY TARGET ORGAN
5.1 Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2032)
5.2 Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Target Organ (2021-2032)
5.3 Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2032)
6.2 Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Application (2021-2032)
6.3 Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2032)
7.2 North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2032)
7.3 North America Normothermic Organ Perfusion Systems for Transplantation Market Size by Country
7.3.1 North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2021-2032)
7.3.2 North America Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2032)
8.2 Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2032)
8.3 Europe Normothermic Organ Perfusion Systems for Transplantation Market Size by Country
8.3.1 Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2021-2032)
8.3.2 Europe Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2032)
9.2 Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Market Size by Region
9.3.1 Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2032)
10.2 South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2032)
10.3 South America Normothermic Organ Perfusion Systems for Transplantation Market Size by Country
10.3.1 South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2021-2032)
10.3.2 South America Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2032)
11.2 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Market Size by Country
11.3.1 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Normothermic Organ Perfusion Systems for Transplantation Market Drivers
12.2 Normothermic Organ Perfusion Systems for Transplantation Market Restraints
12.3 Normothermic Organ Perfusion Systems for Transplantation Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Normothermic Organ Perfusion Systems for Transplantation and Key Manufacturers
13.2 Manufacturing Costs Percentage of Normothermic Organ Perfusion Systems for Transplantation
13.3 Normothermic Organ Perfusion Systems for Transplantation Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Normothermic Organ Perfusion Systems for Transplantation Typical Distributors
14.3 Normothermic Organ Perfusion Systems for Transplantation Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Target Organ, (USD Million), 2021 & 2025 & 2032
Table 2. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Target Organ, (USD Million), 2021 & 2025 & 2032
Table 3. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Donor Type, (USD Million), 2021 & 2025 & 2032
Table 4. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table 6. Terumo Corporation Major Business
Table 7. Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 8. Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Terumo Corporation Recent Developments/Updates
Table 10. TransMedics Group, Inc. Basic Information, Manufacturing Base and Competitors
Table 11. TransMedics Group, Inc. Major Business
Table 12. TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 13. TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. TransMedics Group, Inc. Recent Developments/Updates
Table 15. XVIVO Perfusion AB Basic Information, Manufacturing Base and Competitors
Table 16. XVIVO Perfusion AB Major Business
Table 17. XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 18. XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. XVIVO Perfusion AB Recent Developments/Updates
Table 20. Aferetica S.r.l. Basic Information, Manufacturing Base and Competitors
Table 21. Aferetica S.r.l. Major Business
Table 22. Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 23. Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Aferetica S.r.l. Recent Developments/Updates
Table 25. Beijing TsingHan Medical Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 26. Beijing TsingHan Medical Technology Co., Ltd. Major Business
Table 27. Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 28. Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Beijing TsingHan Medical Technology Co., Ltd. Recent Developments/Updates
Table 30. EBERS Medical Technology S.L. Basic Information, Manufacturing Base and Competitors
Table 31. EBERS Medical Technology S.L. Major Business
Table 32. EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 33. EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. EBERS Medical Technology S.L. Recent Developments/Updates
Table 35. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 36. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Manufacturer (2021-2026) & (USD Million)
Table 37. Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Manufacturer (2021-2026) & (K US$/Unit)
Table 38. Market Position of Manufacturers in Normothermic Organ Perfusion Systems for Transplantation, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 39. Head Office and Normothermic Organ Perfusion Systems for Transplantation Production Site of Key Manufacturer
Table 40. Normothermic Organ Perfusion Systems for Transplantation Market: Company Product Type Footprint
Table 41. Normothermic Organ Perfusion Systems for Transplantation Market: Company Product Application Footprint
Table 42. Normothermic Organ Perfusion Systems for Transplantation New Market Entrants and Barriers to Market Entry
Table 43. Normothermic Organ Perfusion Systems for Transplantation Mergers, Acquisition, Agreements, and Collaborations
Table 44. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 45. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Region (2021-2026) & (Units)
Table 46. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Region (2027-2032) & (Units)
Table 47. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Region (2021-2026) & (USD Million)
Table 48. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Region (2027-2032) & (USD Million)
Table 49. Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Region (2021-2026) & (K US$/Unit)
Table 50. Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Region (2027-2032) & (K US$/Unit)
Table 51. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2026) & (Units)
Table 52. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2027-2032) & (Units)
Table 53. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Target Organ (2021-2026) & (USD Million)
Table 54. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Target Organ (2027-2032) & (USD Million)
Table 55. Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2021-2026) & (K US$/Unit)
Table 56. Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2027-2032) & (K US$/Unit)
Table 57. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2026) & (Units)
Table 58. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2027-2032) & (Units)
Table 59. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Application (2021-2026) & (USD Million)
Table 60. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Application (2027-2032) & (USD Million)
Table 61. Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Application (2021-2026) & (K US$/Unit)
Table 62. Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Application (2027-2032) & (K US$/Unit)
Table 63. North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2026) & (Units)
Table 64. North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2027-2032) & (Units)
Table 65. North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2026) & (Units)
Table 66. North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2027-2032) & (Units)
Table 67. North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2021-2026) & (Units)
Table 68. North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2027-2032) & (Units)
Table 69. North America Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2021-2026) & (USD Million)
Table 70. North America Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2027-2032) & (USD Million)
Table 71. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2026) & (Units)
Table 72. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2027-2032) & (Units)
Table 73. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2026) & (Units)
Table 74. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2027-2032) & (Units)
Table 75. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2021-2026) & (Units)
Table 76. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2027-2032) & (Units)
Table 77. Europe Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2021-2026) & (USD Million)
Table 78. Europe Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2027-2032) & (USD Million)
Table 79. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2026) & (Units)
Table 80. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2027-2032) & (Units)
Table 81. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2026) & (Units)
Table 82. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2027-2032) & (Units)
Table 83. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Region (2021-2026) & (Units)
Table 84. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Region (2027-2032) & (Units)
Table 85. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Region (2027-2032) & (USD Million)
Table 87. South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2026) & (Units)
Table 88. South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2027-2032) & (Units)
Table 89. South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2026) & (Units)
Table 90. South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2027-2032) & (Units)
Table 91. South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2021-2026) & (Units)
Table 92. South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2027-2032) & (Units)
Table 93. South America Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2021-2026) & (USD Million)
Table 94. South America Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2027-2032) & (USD Million)
Table 95. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2026) & (Units)
Table 96. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2027-2032) & (Units)
Table 97. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2026) & (Units)
Table 98. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2027-2032) & (Units)
Table 99. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2021-2026) & (Units)
Table 100. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2027-2032) & (Units)
Table 101. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2027-2032) & (USD Million)
Table 103. Normothermic Organ Perfusion Systems for Transplantation Raw Material
Table 104. Key Manufacturers of Normothermic Organ Perfusion Systems for Transplantation Raw Materials
Table 105. Normothermic Organ Perfusion Systems for Transplantation Typical Distributors
Table 106. Normothermic Organ Perfusion Systems for Transplantation Typical Customers
Table 1. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Target Organ, (USD Million), 2021 & 2025 & 2032
Table 2. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Target Organ, (USD Million), 2021 & 2025 & 2032
Table 3. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Donor Type, (USD Million), 2021 & 2025 & 2032
Table 4. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table 6. Terumo Corporation Major Business
Table 7. Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 8. Terumo Corporation Normothermic Organ Perfusion Systems for Transplantation Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Terumo Corporation Recent Developments/Updates
Table 10. TransMedics Group, Inc. Basic Information, Manufacturing Base and Competitors
Table 11. TransMedics Group, Inc. Major Business
Table 12. TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 13. TransMedics Group, Inc. Normothermic Organ Perfusion Systems for Transplantation Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. TransMedics Group, Inc. Recent Developments/Updates
Table 15. XVIVO Perfusion AB Basic Information, Manufacturing Base and Competitors
Table 16. XVIVO Perfusion AB Major Business
Table 17. XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 18. XVIVO Perfusion AB Normothermic Organ Perfusion Systems for Transplantation Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. XVIVO Perfusion AB Recent Developments/Updates
Table 20. Aferetica S.r.l. Basic Information, Manufacturing Base and Competitors
Table 21. Aferetica S.r.l. Major Business
Table 22. Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 23. Aferetica S.r.l. Normothermic Organ Perfusion Systems for Transplantation Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Aferetica S.r.l. Recent Developments/Updates
Table 25. Beijing TsingHan Medical Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 26. Beijing TsingHan Medical Technology Co., Ltd. Major Business
Table 27. Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 28. Beijing TsingHan Medical Technology Co., Ltd. Normothermic Organ Perfusion Systems for Transplantation Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Beijing TsingHan Medical Technology Co., Ltd. Recent Developments/Updates
Table 30. EBERS Medical Technology S.L. Basic Information, Manufacturing Base and Competitors
Table 31. EBERS Medical Technology S.L. Major Business
Table 32. EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Product and Services
Table 33. EBERS Medical Technology S.L. Normothermic Organ Perfusion Systems for Transplantation Sales Quantity (Units), Average Price (K US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. EBERS Medical Technology S.L. Recent Developments/Updates
Table 35. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 36. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Manufacturer (2021-2026) & (USD Million)
Table 37. Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Manufacturer (2021-2026) & (K US$/Unit)
Table 38. Market Position of Manufacturers in Normothermic Organ Perfusion Systems for Transplantation, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 39. Head Office and Normothermic Organ Perfusion Systems for Transplantation Production Site of Key Manufacturer
Table 40. Normothermic Organ Perfusion Systems for Transplantation Market: Company Product Type Footprint
Table 41. Normothermic Organ Perfusion Systems for Transplantation Market: Company Product Application Footprint
Table 42. Normothermic Organ Perfusion Systems for Transplantation New Market Entrants and Barriers to Market Entry
Table 43. Normothermic Organ Perfusion Systems for Transplantation Mergers, Acquisition, Agreements, and Collaborations
Table 44. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 45. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Region (2021-2026) & (Units)
Table 46. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Region (2027-2032) & (Units)
Table 47. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Region (2021-2026) & (USD Million)
Table 48. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Region (2027-2032) & (USD Million)
Table 49. Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Region (2021-2026) & (K US$/Unit)
Table 50. Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Region (2027-2032) & (K US$/Unit)
Table 51. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2026) & (Units)
Table 52. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2027-2032) & (Units)
Table 53. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Target Organ (2021-2026) & (USD Million)
Table 54. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Target Organ (2027-2032) & (USD Million)
Table 55. Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2021-2026) & (K US$/Unit)
Table 56. Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2027-2032) & (K US$/Unit)
Table 57. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2026) & (Units)
Table 58. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2027-2032) & (Units)
Table 59. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Application (2021-2026) & (USD Million)
Table 60. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Application (2027-2032) & (USD Million)
Table 61. Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Application (2021-2026) & (K US$/Unit)
Table 62. Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Application (2027-2032) & (K US$/Unit)
Table 63. North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2026) & (Units)
Table 64. North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2027-2032) & (Units)
Table 65. North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2026) & (Units)
Table 66. North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2027-2032) & (Units)
Table 67. North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2021-2026) & (Units)
Table 68. North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2027-2032) & (Units)
Table 69. North America Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2021-2026) & (USD Million)
Table 70. North America Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2027-2032) & (USD Million)
Table 71. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2026) & (Units)
Table 72. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2027-2032) & (Units)
Table 73. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2026) & (Units)
Table 74. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2027-2032) & (Units)
Table 75. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2021-2026) & (Units)
Table 76. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2027-2032) & (Units)
Table 77. Europe Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2021-2026) & (USD Million)
Table 78. Europe Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2027-2032) & (USD Million)
Table 79. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2026) & (Units)
Table 80. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2027-2032) & (Units)
Table 81. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2026) & (Units)
Table 82. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2027-2032) & (Units)
Table 83. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Region (2021-2026) & (Units)
Table 84. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Region (2027-2032) & (Units)
Table 85. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Region (2027-2032) & (USD Million)
Table 87. South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2026) & (Units)
Table 88. South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2027-2032) & (Units)
Table 89. South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2026) & (Units)
Table 90. South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2027-2032) & (Units)
Table 91. South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2021-2026) & (Units)
Table 92. South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2027-2032) & (Units)
Table 93. South America Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2021-2026) & (USD Million)
Table 94. South America Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2027-2032) & (USD Million)
Table 95. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2021-2026) & (Units)
Table 96. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Target Organ (2027-2032) & (Units)
Table 97. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2021-2026) & (Units)
Table 98. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Application (2027-2032) & (Units)
Table 99. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2021-2026) & (Units)
Table 100. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity by Country (2027-2032) & (Units)
Table 101. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Country (2027-2032) & (USD Million)
Table 103. Normothermic Organ Perfusion Systems for Transplantation Raw Material
Table 104. Key Manufacturers of Normothermic Organ Perfusion Systems for Transplantation Raw Materials
Table 105. Normothermic Organ Perfusion Systems for Transplantation Typical Distributors
Table 106. Normothermic Organ Perfusion Systems for Transplantation Typical Customers
LIST OF FIGURES
Figure 1. Normothermic Organ Perfusion Systems for Transplantation Picture
Figure 2. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Target Organ, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Target Organ in 2025
Figure 4. Liver Examples
Figure 5. Heart Examples
Figure 6. Lung Examples
Figure 7. Kidney Examples
Figure 8. Others Examples
Figure 9. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Target Organ, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Target Organ in 2025
Figure 11. Blood-based Perfusate Examples
Figure 12. Acellular Perfusate Examples
Figure 13. Others Examples
Figure 14. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Donor Type, (USD Million), 2021 & 2025 & 2032
Figure 15. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Donor Type in 2025
Figure 16. Donation after Brain Death DBD Examples
Figure 17. Donation after Circulatory Death DCD Examples
Figure 18. Others Examples
Figure 19. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 20. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Application in 2025
Figure 21. Hospitals Transplant Centers Examples
Figure 22. Organ Procurement Organizations (OPOs) Examples
Figure 23. Specialty Clinics Examples
Figure 24. Research Laboratories Examples
Figure 25. Others Examples
Figure 26. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 27. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 28. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity (2021-2032) & (Units)
Figure 29. Global Normothermic Organ Perfusion Systems for Transplantation Price (2021-2032) & (K US$/Unit)
Figure 30. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Manufacturer in 2025
Figure 31. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Manufacturer in 2025
Figure 32. Producer Shipments of Normothermic Organ Perfusion Systems for Transplantation by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 33. Top 3 Normothermic Organ Perfusion Systems for Transplantation Manufacturer (Revenue) Market Share in 2025
Figure 34. Top 6 Normothermic Organ Perfusion Systems for Transplantation Manufacturer (Revenue) Market Share in 2025
Figure 35. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Region (2021-2032)
Figure 36. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value Market Share by Region (2021-2032)
Figure 37. North America Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 38. Europe Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 39. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 40. South America Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 41. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 42. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Target Organ (2021-2032)
Figure 43. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value Market Share by Target Organ (2021-2032)
Figure 44. Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2021-2032) & (K US$/Unit)
Figure 45. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Application (2021-2032)
Figure 46. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Application (2021-2032)
Figure 47. Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Application (2021-2032) & (K US$/Unit)
Figure 48. North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Target Organ (2021-2032)
Figure 49. North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Application (2021-2032)
Figure 50. North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Country (2021-2032)
Figure 51. North America Normothermic Organ Perfusion Systems for Transplantation Consumption Value Market Share by Country (2021-2032)
Figure 52. United States Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 53. Canada Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 54. Mexico Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 55. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Target Organ (2021-2032)
Figure 56. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Application (2021-2032)
Figure 57. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Country (2021-2032)
Figure 58. Europe Normothermic Organ Perfusion Systems for Transplantation Consumption Value Market Share by Country (2021-2032)
Figure 59. Germany Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 60. France Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 61. United Kingdom Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 62. Russia Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 63. Italy Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 64. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Target Organ (2021-2032)
Figure 65. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Application (2021-2032)
Figure 66. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Region (2021-2032)
Figure 67. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Consumption Value Market Share by Region (2021-2032)
Figure 68. China Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 69. Japan Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 70. South Korea Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 71. India Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 72. Southeast Asia Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 73. Australia Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 74. South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Target Organ (2021-2032)
Figure 75. South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Application (2021-2032)
Figure 76. South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Country (2021-2032)
Figure 77. South America Normothermic Organ Perfusion Systems for Transplantation Consumption Value Market Share by Country (2021-2032)
Figure 78. Brazil Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 79. Argentina Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 80. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Target Organ (2021-2032)
Figure 81. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Application (2021-2032)
Figure 82. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Country (2021-2032)
Figure 83. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Consumption Value Market Share by Country (2021-2032)
Figure 84. Turkey Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 85. Egypt Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 86. Saudi Arabia Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 87. South Africa Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 88. Normothermic Organ Perfusion Systems for Transplantation Market Drivers
Figure 89. Normothermic Organ Perfusion Systems for Transplantation Market Restraints
Figure 90. Normothermic Organ Perfusion Systems for Transplantation Market Trends
Figure 91. Porters Five Forces Analysis
Figure 92. Manufacturing Cost Structure Analysis of Normothermic Organ Perfusion Systems for Transplantation in 2025
Figure 93. Manufacturing Process Analysis of Normothermic Organ Perfusion Systems for Transplantation
Figure 94. Normothermic Organ Perfusion Systems for Transplantation Industrial Chain
Figure 95. Sales Channel: Direct to End-User vs Distributors
Figure 96. Direct Channel Pros & Cons
Figure 97. Indirect Channel Pros & Cons
Figure 98. Methodology
Figure 99. Research Process and Data Source
Figure 1. Normothermic Organ Perfusion Systems for Transplantation Picture
Figure 2. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Target Organ, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Target Organ in 2025
Figure 4. Liver Examples
Figure 5. Heart Examples
Figure 6. Lung Examples
Figure 7. Kidney Examples
Figure 8. Others Examples
Figure 9. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Target Organ, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Target Organ in 2025
Figure 11. Blood-based Perfusate Examples
Figure 12. Acellular Perfusate Examples
Figure 13. Others Examples
Figure 14. Global Normothermic Organ Perfusion Systems for Transplantation Revenue by Donor Type, (USD Million), 2021 & 2025 & 2032
Figure 15. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Donor Type in 2025
Figure 16. Donation after Brain Death DBD Examples
Figure 17. Donation after Circulatory Death DCD Examples
Figure 18. Others Examples
Figure 19. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 20. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Application in 2025
Figure 21. Hospitals Transplant Centers Examples
Figure 22. Organ Procurement Organizations (OPOs) Examples
Figure 23. Specialty Clinics Examples
Figure 24. Research Laboratories Examples
Figure 25. Others Examples
Figure 26. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 27. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 28. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity (2021-2032) & (Units)
Figure 29. Global Normothermic Organ Perfusion Systems for Transplantation Price (2021-2032) & (K US$/Unit)
Figure 30. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Manufacturer in 2025
Figure 31. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Manufacturer in 2025
Figure 32. Producer Shipments of Normothermic Organ Perfusion Systems for Transplantation by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 33. Top 3 Normothermic Organ Perfusion Systems for Transplantation Manufacturer (Revenue) Market Share in 2025
Figure 34. Top 6 Normothermic Organ Perfusion Systems for Transplantation Manufacturer (Revenue) Market Share in 2025
Figure 35. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Region (2021-2032)
Figure 36. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value Market Share by Region (2021-2032)
Figure 37. North America Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 38. Europe Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 39. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 40. South America Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 41. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 42. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Target Organ (2021-2032)
Figure 43. Global Normothermic Organ Perfusion Systems for Transplantation Consumption Value Market Share by Target Organ (2021-2032)
Figure 44. Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Target Organ (2021-2032) & (K US$/Unit)
Figure 45. Global Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Application (2021-2032)
Figure 46. Global Normothermic Organ Perfusion Systems for Transplantation Revenue Market Share by Application (2021-2032)
Figure 47. Global Normothermic Organ Perfusion Systems for Transplantation Average Price by Application (2021-2032) & (K US$/Unit)
Figure 48. North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Target Organ (2021-2032)
Figure 49. North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Application (2021-2032)
Figure 50. North America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Country (2021-2032)
Figure 51. North America Normothermic Organ Perfusion Systems for Transplantation Consumption Value Market Share by Country (2021-2032)
Figure 52. United States Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 53. Canada Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 54. Mexico Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 55. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Target Organ (2021-2032)
Figure 56. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Application (2021-2032)
Figure 57. Europe Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Country (2021-2032)
Figure 58. Europe Normothermic Organ Perfusion Systems for Transplantation Consumption Value Market Share by Country (2021-2032)
Figure 59. Germany Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 60. France Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 61. United Kingdom Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 62. Russia Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 63. Italy Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 64. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Target Organ (2021-2032)
Figure 65. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Application (2021-2032)
Figure 66. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Region (2021-2032)
Figure 67. Asia-Pacific Normothermic Organ Perfusion Systems for Transplantation Consumption Value Market Share by Region (2021-2032)
Figure 68. China Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 69. Japan Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 70. South Korea Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 71. India Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 72. Southeast Asia Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 73. Australia Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 74. South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Target Organ (2021-2032)
Figure 75. South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Application (2021-2032)
Figure 76. South America Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Country (2021-2032)
Figure 77. South America Normothermic Organ Perfusion Systems for Transplantation Consumption Value Market Share by Country (2021-2032)
Figure 78. Brazil Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 79. Argentina Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 80. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Target Organ (2021-2032)
Figure 81. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Application (2021-2032)
Figure 82. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Sales Quantity Market Share by Country (2021-2032)
Figure 83. Middle East & Africa Normothermic Organ Perfusion Systems for Transplantation Consumption Value Market Share by Country (2021-2032)
Figure 84. Turkey Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 85. Egypt Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 86. Saudi Arabia Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 87. South Africa Normothermic Organ Perfusion Systems for Transplantation Consumption Value (2021-2032) & (USD Million)
Figure 88. Normothermic Organ Perfusion Systems for Transplantation Market Drivers
Figure 89. Normothermic Organ Perfusion Systems for Transplantation Market Restraints
Figure 90. Normothermic Organ Perfusion Systems for Transplantation Market Trends
Figure 91. Porters Five Forces Analysis
Figure 92. Manufacturing Cost Structure Analysis of Normothermic Organ Perfusion Systems for Transplantation in 2025
Figure 93. Manufacturing Process Analysis of Normothermic Organ Perfusion Systems for Transplantation
Figure 94. Normothermic Organ Perfusion Systems for Transplantation Industrial Chain
Figure 95. Sales Channel: Direct to End-User vs Distributors
Figure 96. Direct Channel Pros & Cons
Figure 97. Indirect Channel Pros & Cons
Figure 98. Methodology
Figure 99. Research Process and Data Source
